throbber
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`HARVEST TRADING GROUP, INC.,
`Petition
`
`v.
`
`VIREO SYSTEMS, INC. AND
`UNEMED CORPORATION,
`
`Patent Owners
`
`U.S. PATENT NO. 8,354,450
`IPR 2016-00945
`
`U.S. PATENT NO. 8,962,685
`IPR 2016-00947
`
`DECLARATION OF MARK FAULKNER
`
`
`
`Ex. 2001
`
`
`
`
`
`
`Vireo Systems, Inc. Ex. 2001 - 001
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`DECLARATION
`I, Mark Faulkner, hereby declare and say:
`
`1. I am over the age of eighteen (18) and have personal knowledge of the matters
`
`set forth herein.
`
`2. I am the President of Vireo Systems, Inc. (“Vireo” or “Owner”).
`
`3. Vireo is one of the co-owners of U.S. Patent Nos. 8,354,450 (the “ ‘450
`
`Patent”), 8,962,685 (the “ ‘685 Patent”), 8,026,385 (the “ ‘385 Patent”), and
`
`7,608,641 (the “ ‘641 Patent).
`
`4. I understand that the ‘450 Patent is subject to a petition for inter partes review
`
`in Proceeding No. IPR2016-00945 filed by the Petitioner, Harvest Trading
`
`Group, Inc., and that the ‘685 Patent is subject to a petition for inter partes
`
`review in Proceeding No. IPR2016-00947, also filed by Harvest Trading
`
`Group, Inc. I further understand that the ‘450 Patent is identified as a
`
`continuation in part of the ‘385 Patent, the ‘385 Patent is a continuation of the
`
`‘450 Patent, and that the ‘685 Patent is a divisional of the ‘450 Patent.
`
`5. Vireo and ProMera Health, LLC (“ProMera”) were parties to a Product
`
`Development and Manufacturing Agreement (“PDMA”) under which Vireo
`
`was responsible for manufacturing a creatine hydrochloride nutritional
`
`supplement, and ProMera was to market and distribute creatine hydrochloride
`
`Vireo Systems, Inc. Ex. 2001 - 002
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`nutritional supplements covered by the ‘450 and ‘685 Patents under the CON-
`
`CRET brand.
`
`6. ProMera is a limited liability company with three members, which include
`
`HTG Ventures, LLC (51% ownership) and the Patent Owner (Vireo, 42%
`
`ownership). During the PDMA, ProMera’s managers were John Lewis, Tim
`
`Kensinger (“Kensinger”), and myself. Petitioner was identified as a resource
`
`ProMera would use to market and distribute creatine hydrochloride. HTG
`
`Ventures appointed managers Kensinger and Lewis, who have caused
`
`ProMera to use Petitioner as an exclusive distributor, which is the subject of
`
`a separate lawsuits that are currently pending. Upon learning of HTG
`
`Ventures’ and its appointed managers’ misconduct, Vireo terminated the
`
`PDMA (and ProMera’s license) and I resigned as manager. ProMera and
`
`Petitioner continued to sell creatine hydrochloride in violation of the patents.
`
`7. Petitioner (Harvest Trading Group, Inc.) is a corporation, and has three
`
`officers: James Lewis (President), John Lewis (Treasurer), and Kensinger
`
`(Secretary). These same three individuals are also the owners of Petitioner.
`
`8. HTG Ventures, LLC, a limited liability company, has three members who
`
`coincide with the officers and owners of Petitioner: John Lewis, James Lewis,
`
`and Kensinger. The managers of HTG Ventures are also the same three
`
`individuals. HTG Ventures is a holding company for its owners’ interest in
`
`Vireo Systems, Inc. Ex. 2001 - 003
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`ProMera (51% ownership). Petitioner and its owners (John Lewis, James
`
`Lewis, and Kensinger) caused HTG Ventures to manage ProMera according
`
`to their wishes.
`
`9. Harvest Trading Group Technologies, Inc. (“HTG Tech”) is an affiliate of,
`
`and shares much of the same ownership of, Petitioner. HTG Tech provided
`
`certain operational support to ProMera in its sale and distribution of CON-
`
`CRET.
`
`10. As President of a member of ProMera, I became familiar with the operation
`
`of ProMera, with the owners and managers of Petitioner (Harvest Trading
`
`Group, Inc.) and its affiliates (HTG Ventures and HTG Tech), and the
`
`individuals that primarily controlled the operation of these entities.
`
`11. I was personally involved in a number of meetings that included John Lewis,
`
`James Lewis, and Kensinger discussing operation of ProMera and the
`
`distribution and sale of the CON-CRET product. In those meetings,
`
`Kensinger provided the same amount of input, influence, and control as that
`
`provided by John Lewis and James Lewis. John Lewis, James Lewis and
`
`Kensinger acted as co-equals in controlling the operations. Kensinger is a
`
`manager of ProMera.
`
`Vireo Systems, Inc. Ex. 2001 - 004
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`12. I have direct knowledge of Kensinger controlling and directing various
`
`aspects of ProMera’s operations and litigation strategy. First, when Vireo and
`
`ProMera negotiated amendments or changes to the PDMA, Kensinger
`
`communicated and directed ProMera’s position as Vireo’s licensee on
`
`intellectual property issues and its obligations for defense.
`
`13. Second, Kensinger also directed or influenced various aspects of ProMera’s
`
`implementation of its obligations under the PDMA, including directly
`
`influencing ProMera’s retail strategy for sale of the CON-CRET products, and
`
`resolving disputes with Vireo over various fees and charges.
`
`14. While the PDMA was in place, ProMera sold the CON-CRET nutritional
`
`supplements using the creatine hydrochloride supplied by Vireo to its
`
`managers’ affiliate, Petitioner. ProMera or Petitioner, under the ProMera
`
`brand, advertised the CON-CRET products as “patented” and its packaging
`
`included a reference to the ‘450 and ‘685 Patents.
`
`15. The patent application that ultimately issued as the ‘450 Patent was filed as a
`
`continuation in part of the ‘385 Patent on October 21, 2010. While the PDMA
`
`was in place, James P. Lewis, John T. Lewis, and Kensinger (the principals of
`
`ProMera and Petitioner) were provided copies of the pending patent
`
`applications, communications to and from the United States Patent and
`
`Trademark Office (“USPTO”), and provided input on the prosecution of the
`
`Vireo Systems, Inc. Ex. 2001 - 005
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`application. ProMera was even responsible for payment of, and did in fact
`
`pay, the attorneys’ fees associated with the prosecution of the ‘450 Patent and
`
`‘685 Patent.
`
`16. As a result of Petitioner’s and its owners misconduct, Vireo terminated the
`
`PDMA on February 5, 2015. After termination, Petitioner and its affiliates
`
`continued to sell the creatine hydrochloride-based CON-CRET nutritional
`
`supplement using an alternative manufacturer of creatine hydrochloride.
`
`Petitioner continued and continues to advertise the unpatented creatine
`
`hydrochloride as CON-CRET, which had been branded as a patented product.
`
`17. Petitioner and ProMera sued Vireo seeking a declaratory judgment to
`
`invalidate the ‘450 Patent and ‘685 Patent in the United States District Court
`
`in Massachusetts. (“Massachusetts Patent Litigation”). Vireo sued Petitioner
`
`and ProMera for infringement of the ‘450 Patent and ‘685 Patent (among other
`
`claims) in the United States District Court of Nebraska on April 22, 2015.
`
`The Massachusetts Patent Litigation was transferred to the United States
`
`District Court of Nebraska.
`
`18. One year later, on April 22, 2016, Petitioner filed this IPR.
`
`Conclusion
`
`Vireo Systems, Inc. Ex. 2001 - 006
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Vireo Systems, Inc. Ex. 2001 - 007
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket